Journal of Translational Medicine DOI: 10.1186/s12967-022-03422-7 (2022)

miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.